Knowledge Hub
Category: Global initiatives - Type: Webinar -
La Stratégie de priorisation des innovations en matière de vaccins (VIPS en anglais pour "Vaccine Innovation Prioritisation Strategy") représente une collaboration sans précédent de trois ans...
La première journée de la 16ème conférence TechNet s'ouvre sur les stratégies de la chaîne d'approvisionnement en matière de vaccination et sur la réponse face à la Covid-19.
La deuxième journée de la 16e conférence TechNet s'ouvre sur la gestion des vaccins et les équipements de la chaîne du froid (CCE).
Lors de cette séance plénière de clôture du deuxième jour, nous jetons un regard sur le passé, sur l'avenir et nous nous mettons dans l'ambiance du Marché des fabricants.
The opening ceremony of the 16th TechNet Conference.
The Vaccine Innovation Prioritisation Strategy (VIPS) represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates...
During the session, we will not only learn about how UPS is currently contributing to making the global, regional and local supply chains capable and ready to deliver future Covid19 vaccines, but...
TechNet-21 is a member of the Partnership of Immunization Networks (PIN), which has been created to strengthen collaboration between organizations that serve distinct yet interconnected online...
Day two of the 16th TechNet Conference opens with a focus on vaccine management and cold chain equipment (CCE).
In this closing plenary session of Day two, we take a look back, look ahead, and get in the mood for the Manufacturer Marketplace.
Keynote address delivered at the 2021 GVIRF meeting.
0:36 - Introduction.
3:43 - The enduring dilemma of 20 million unvaccinated children: Equity and access solutions in IA2030, Kate O'Brien, WHO.
24:18 - Impact of COVID-19 on coverage and equity,...
0:00 - Anant Shah, Merck.
21:52 - Ahd Hamidi, Batavia Biosciences.
37:41 - Casey Selwyn, Bill & Melinda Gates Foundation.
54:32 - Block 1 Q&A, Antu Dey, Anant Shah, Ahd Hamidi, Casey...
0:00 - Ana Maria Henao =-Restrepo, WHO.
16:11 - Melanie Saville, CEPI.
34:20 - Barney Graham, NIAID/NIH.
54:35 - Block 1 Q&A, Helen Rees, Ana Maria Henao-Restrepo, Melanie Saville, Barney...
2:00 - Salmonella typhi, Sushant Sahastrabuddhe, IVI.
20:32 - Schistosomiasis, Robert Bergquist, Geospatial Health.
36:26 - HPV, Aimee Kreimer, NCI/NIH.
52:46 - Novel OPV, Ananda Bandyopadhyay,...
2:02 - HIV: Linda-Gail Bekker.
22:36 - TB: Ann Ginsberg.
42::50 - Malaria: Sodiomon B. Sirima.
56:49 - Block 1 Q&A, Norman Baylor, Linda-Gail Bekker, Ann Ginsberg.
1:23:28 - Block 2 Q&A, Lucky...
0:00 - Controlled human malaria infection—tool for accelerating vaccine development, Melissa Kapulu.
20:52 - Typhoid controlled human infection model, Andrew Pollard.
35:04 - Respiratory virus...
0:00 - A conversation on the challenges and opportunities for innovation in vaccination, Jon Abramson and Alejandro Cravioto.
9:24 - Transformative concepts for mass vaccination and pandemic...
Vaccinology in 2021, pandemic preparedness and response, and challenges for the next decade
Keynote address delivered at the 2021 GVIRF.
3:28 - Nucleic acid vaccines: Is it all done? Christian Mandl. 21:37 - Viral Vectored vaccine platform technologies, Sarah Gilbert. 33:49 - Adjuvants, . 45:16 - Block 1 Q&A, Christian Mandl, Nathalie...
0:05 - Opportunities, risks, and potential valleys of death, David Kaslow, PATH. 16:22 - Is there a role for early policy decision? Rino Rappuoli, GSK. 27:58 - Building the concept of Preferred...
0:36 - Introduction, Peter Hotez. 2:48 - Decision-making and prioritization of vaccines to address public health needs in low- and middle-income countries, Bill Hausdorff. 15:14 - Prioritization of...
Learnings from COVID-19 and applications to other global health challenges. Topics include how a correlate of protection (CoP) is discovered and applied for vaccine development; identification of a...
The impact on families of inequitable access, achieving COVID-19 vaccination, COVID-19 vaccine research: speed vs. equity, and the role of WHO in achieving vaccines equity.